Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1730 to 1779 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
865\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol 3-kinase regulatory alpha subunit (pi3-kinase p85-alpha subunit) (ptdins-3-kinase p85-alpha) (pi3k). [source:swissprot;acc:p27986]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5595.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6173.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10322\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
866\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
muts protein homolog 4. [source:swissprot;acc:o15457]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7528.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7832.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04031\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ring finger protein 38. [source:refseq;acc:nm\_022781]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5595.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6173.23\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.10322\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
867\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol 3-kinase regulatory gamma subunit (pi3-kinase p85-gamma subunit) (ptdins-3-kinase p85-gamma) (p55pik). [source:swissprot;acc:q92569]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm6 (sm protein f). [source:swissprot;acc:q9y4y8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7897.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8216.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0403\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
868\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
electron transfer flavoprotein beta-subunit (beta-etf). [source:swissprot;acc:p38117]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8743.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9094.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04018\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sterol regulatory element binding protein cleavage-activating protein (srebp cleavage-activating protein) (scap). [source:swissprot;acc:q12770]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5595.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6173.23\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.10322\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
869\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp synthase beta chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p06576]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 1 (ec 2.7.7.41) (cdp-diglyceride synthetase 1) (cdp-diglyceride pyrophosphorylase 1) (cdp- diacylglycerol synthase 1) (cds 1) (ctp:phosphatidate cytidylyltransferase 1) (cdp-dag synthase 1) (cdp-dg synthetase 1). [source:swissprot;acc:q92903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8307.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8640.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04017\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
870\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidylinositol 3-kinase regulatory beta subunit (pi3-kinase p85-beta subunit) (ptdins-3-kinase p85-beta). [source:swissprot;acc:o00459]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5595.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6173.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10322\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding region containing protein 2 (hepatocellular carcinoma protein 1) (splicing factor hcc1). [source:swissprot;acc:q14498]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7727.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8037.91\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04017\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
871\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glioma tumor suppressor candidate region gene 2 protein (p60). [source:swissprot;acc:q9nzm5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7721.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8031.92\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein bap28. [source:swissprot;acc:q9h583]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3956.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4364.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10313\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
872\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
epididymal secretory protein e1 precursor (niemann-pick disease type c2 protein) (epi-1) (he1) (epididymal secretory protein 14.6) (esp14.6). [source:swissprot;acc:q15668]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6781.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7480.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1031\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 2. [source:swissprot;acc:o15127]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8306.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8639.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04013\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
873\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
programmed cell death protein 5 (tfar19 protein) (tf-1 cell apoptosis related gene-19 protein). [source:swissprot;acc:o14737]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4749.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5237.77\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1028\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 3. [source:swissprot;acc:o14828]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8306.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8639.8\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04013\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
874\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ca2+-dependent endoplasmic reticulum nucleoside diphosphatase; apyrase; soluble calcium-activated nucleotidase scan-1. [source:refseq;acc:nm\_138793]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9921.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10941.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10278\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 1. [source:swissprot;acc:o15126]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8306.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8639.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04013\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
875\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 2 (ec 2.7.7.41) (cdp-diglyceride synthetase 2) (cdp-diglyceride pyrophosphorylase 2) (cdp- diacylglycerol synthase 2) (cds 2) (ctp:phosphatidate cytidylyltransferase 2) (cdp-dag synthase 2) (cdp-dg synthetase 2). [source:swissprot;acc:o95674]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8305.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8638.86\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0401\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
steroid hormone receptor err2 (estrogen-related receptor, beta) (err-beta) (estrogen receptor-like 2) (err beta-2). [source:swissprot;acc:o95718]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
10263.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
11318.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10277\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
876\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal carnitine octanoyltransferase (ec 2.3.1.-) (cot). [source:swissprot;acc:q9ukg9]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5644.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6223.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10249\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transportin-sr; importin 12. [source:refseq;acc:nm\_012470]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8122.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8447.58\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04008\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
877\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
max protein. [source:swissprot;acc:p25912]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7258.31\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7548.92\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04004\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitotic spindle assembly checkpoint protein mad2b (mad2-like 2) (hrev7). [source:swissprot;acc:q9ui95]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5797.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6391.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10243\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
878\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brg1-binding protein eld/osa1; eld (eyelid)/osa protein. [source:refseq;acc:nm\_020732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7772.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8083.21\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04003\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial 28s ribosomal protein s32 (s32mt) (mrp-s32) (ptd007) (hspc204). [source:swissprot;acc:q9y6g3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5797.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6391.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10243\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
879\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic protein nck2 (nck adaptor protein 2) (sh2/sh3 adaptor protein nck-beta) (nck-2). [source:swissprot;acc:o43639]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8121.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8446.35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04002\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear pore complex protein nup88 (nucleoporin nup88) (88 kda nuclear pore complex protein). [source:swissprot;acc:q99567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5797.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6391.75\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10243\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
880\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (ec 2.3.1.51) (1- agp acyltransferase 2) (1-agpat 2) (lysophosphatidic acid acyltransferase-beta) (lpaat-beta) (1-acylglycerol-3-phosphate o- acyltransferase 2). [source:swissprot;acc:o15120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8256.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8587.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04001\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peptide chain release factor 1, mitochondrial precursor (mrf-1). [source:swissprot;acc:o75570]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5166.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5694.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1023\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
881\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 7 (adp-ribosylation factor-like protein lak). [source:swissprot;acc:p56559]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5912.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6517.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10229\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
red cell acid phosphatase 1, isozyme f (ec 3.1.3.2) (acp1) (low molecular weight phosphotyrosine protein phosphatase) (ec 3.1.3.48) (adipocyte acid phosphatase, isozyme alpha). [source:swissprot;acc:p24666]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7704.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8012.29\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
882\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf-related, matrix-associated, actin-dependent regulator of chromatin subfamily f member 1 (swi-snf complex protein p270) (b120). [source:swissprot;acc:o14497]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7773.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8084.06\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase ac39 subunit) (v-atpase 40 kda accessory protein) (p39) (32 kda accessory protein). [source:swissprot;acc:p12953]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5912.84\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6517.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.10229\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
883\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor-like protein 4. [source:swissprot;acc:p40617]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
l-3-phosphoserine phosphatase (ec 3.1.3.3) (psp) (o-phosphoserine phosphohydrolase) (pspase). [source:swissprot;acc:p78330]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8525.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8866.53\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03996\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
884\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ccaat-binding transcription factor subunit b (cbf-b) (nf-y protein chain a) (nf-ya) (caat-box dna binding protein subunit a). [source:swissprot;acc:p23511]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7404.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7699.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03994\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mannose-p-dolichol utilization defect 1 protein (suppressor of lec15 and lec35 glycosylation mutation homolog) (sl15). [source:swissprot;acc:o75352]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5167.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5695.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10224\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
885\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (ec 2.3.1.51) (1- agp acyltransferase 1) (1-agpat 1) (lysophosphatidic acid acyltransferase-alpha) (lpaat-alpha) (1-acylglycerol-3-phosphate o- acyltransferase 1) (g15 protein). [source:swissprot;acc:q99943]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8255.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8585.64\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03993\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial translational release factor 1-like. [source:refseq;acc:nm\_019041]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5168.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5696.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10219\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
886\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonucleoside-diphosphate reductase m1 chain (ec 1.17.4.1) (ribonucleotide reductase large chain). [source:swissprot;acc:p23921]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7956.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8274.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03988\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
upstream binding protein 1 (lbp-1a). [source:refseq;acc:nm\_014517]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5903.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6506.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10217\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
887\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdp-diacylglycerol--inositol 3-phosphatidyltransferase (ec 2.7.8.11) (phosphatidylinositol synthase) (ptdins synthase) (pi synthase). [source:swissprot;acc:o14735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8220.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8548.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03985\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor cp2; transcription factor cp2, alpha globin. [source:refseq;acc:nm\_005653]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5903.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6506.32\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.10217\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
888\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lbp-9. [source:refseq;acc:nm\_014553]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
syntaxin 1b. [source:swissprot;acc:q15531]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7564.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7865.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03985\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
889\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 11 (26s proteasome regulatory subunit s9) (26s proteasome regulatory subunit p44.5). [source:swissprot;acc:o00231]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
8393.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8727.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03984\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor, arginine/serine-rich 3 (pre-mrna splicing factor srp20) (x16 protein). [source:swissprot;acc:p23152]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5903.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6506.32\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.10217\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
890\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to trna synthetase class ii. [source:refseq;acc:nm\_152268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7925.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8241.15\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.03981\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/